Longitudinal Monitoring of Head Impacts in Elite Junior Ice Hockey
Condition(s) studied
Investigational drug(s) / intervention(s)
Head impact monitoring: Players wear a helmet-mounted sensor (Bearmind) during games and practices to record and quantify head impacts.
Heart rate variability monitoring: Players wear a Polar H10 heart rate monitor to measure heart rate variability at designated times during the season. HRV is assessed pre-, mid-, and post-season, and again 3 days after a diagnosed concussion or sever head impact to evaluate autonomic nervous system responses.
Dual-task cognitive and motor assessment: Players perform a dual-task test combining cognitive and motor activities while wearing a chest-mounted sensor to capture movement and performance metrics. Assessments are conducted pre-, mid-, and post-season, 3 days after a concussion or severe impact , and every 3 days until return to sport after a concussion.
Study summary
This study aims to better understand how head impacts during ice hockey affect the brain and body, especially in young athletes. Even when players do not show clear signs of concussion, these repeated impacts may cause subtle changes in the brain's structure and in how the body regulates basic functions, such as heart rhythm and attention.
This study will follow elite junior ice hockey players over the course of one full season to better understand the effects of repeated head impacts. Using a small helmet sensor (Bearmind) and video analysis, researchers will record and analyze every head impact that occurs during games and practices.
Three times during the season - before, mid-season, and after - players will complete assessments of heart rate variability (using Polar H10 monitors) and a dual-task test that measures attention and coordination.
After any diagnosed concussion, players will be reassessed with both heart rate variability and dual-task testing at 3 days post-injury. Following that, dual-task testing alone will be repeated every 3 days until return to sport. Players who experience a severe head impact, as detected by the helmet sensor, will also be evaluated 3 days after the impact with both heart rate variability and dual-task testing, even if no concussion symptoms are present.
By combining these measures, the study aims to detect early physiological and cognitive changes following head impacts, improve understanding of sub-concussive effects, and support better prevention and management strategies for young athletes.
Eligibility
Primary outcome measure(s)
- Head impact exposure — Continuously throughout one full competitive season during all games and practices (up to 9 months)
Head impacts will be recorded using the Bearmind helmet-mounted sensor during all games and practices over the competitive season.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Centre Hospitalo-Universitaire de Caen Normandie | Caen | Normandy |
More University Hospital, Caen trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07341880 on ClinicalTrials.gov ↗ ← All trials in France